---
$id: https://graph.org.ai/products/commodity/51161545
$type: Product
source: UNSPSC
code: "51161545"
title: "Melquinast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Melquinast

**UNSPSC Code**: 51161545
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C15H16N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0RO0SEU9AY, chemically known as ethyl 6-ethyl-5,6-dihydro-9-methyl-5-oxo-s-triazolo(1,5-c)quinazoline-2-carboxylate. but generally known as melquinast, which bears US NIH Compound Identifier 3045413. European Medicines Agency schedules Melquinast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08729MIG. The term MELQUINAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). MELQUINAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule melquinast under HS 29335995 and SITC 51576. As of Q4 2014, MELQUINAST remains the US FDA Preferred Term for this commodity. Melquinast bears US NLM identifiers UMLS ID C1881774 and NCI Concept Code C66082. SMILES: O=C1N(C2C(C3N1NC(N3)C(=O)OCC)CC(CC2)C)CC.

